A new mechanism of action designed with selectivity and safety in mind.
The Right Treatment
Ganaxolone, a positive allosteric modulator of GABAA, acts on a well-characterized synaptic and extrasynaptic target known for antiepileptic (anti-seizure), anxiolytic (anti-anxiety), and anti-depressive activity.
The Right Formulation
Marinus is developing convenient forms of ganaxolone – IV and oral – to maximize the therapeutic reach to adult and pediatric patients in both acute and chronic care settings.